Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy

详细信息    查看全文

• 作者：Christopher R. Frei ; Sylvie Rehani ; Grace C. Lee ; Natalie K. Boyd ; Erene Attia ; Ashley Pechal ; Rachel S. Britt and Eric M. Mortensen
• 刊名：Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：37
• 期：2
• 页码：195-203
• 全文大小：109K
• ISSN：1875-9114

文摘

To assess the impact of empiric Pseudomonas pharmacotherapy on 30-day mortality in hospitalized patients with community-onset pneumonia stratified according to their risk (low, medium, or high) of drug-resistant pathogens.